Application 021829

Type
NDA
Sponsor
UCB INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NEUPROROTIGOTINEFILM, EXTENDED RELEASE;TRANSDERMAL2MG/24HRYesYes
002NEUPROROTIGOTINEFILM, EXTENDED RELEASE;TRANSDERMAL4MG/24HRYesNo
003NEUPROROTIGOTINEFILM, EXTENDED RELEASE;TRANSDERMAL6MG/24HRYesNo
004NEUPROROTIGOTINEFILM, EXTENDED RELEASE;TRANSDERMAL1MG/24HRYesNo
005NEUPROROTIGOTINEFILM, EXTENDED RELEASE;TRANSDERMAL3MG/24HRYesNo
006NEUPROROTIGOTINEFILM, EXTENDED RELEASE;TRANSDERMAL8MG/24HRYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50474-801NeuprorotigotineUCB, Inc.NDACurrent
50474-801NeuprorotigotineUCB, Inc.NDACurrent
50474-801NeuprorotigotineUCB, Inc.NDACurrent
50474-801NeuprorotigotineUCB, Inc.NDACurrent
50474-801NeuprorotigotineUCB, Inc.NDACurrent
50474-802NeuprorotigotineUCB, Inc.NDACurrent
50474-802NeuprorotigotineUCB, Inc.NDACurrent
50474-802NeuprorotigotineUCB, Inc.NDACurrent
50474-802NeuprorotigotineUCB, Inc.NDACurrent
50474-802NeuprorotigotineUCB, Inc.NDACurrent
50474-803NeuprorotigotineUCB, Inc.NDACurrent
50474-803NeuprorotigotineUCB, Inc.NDACurrent
50474-803NeuprorotigotineUCB, Inc.NDACurrent
50474-803NeuprorotigotineUCB, Inc.NDACurrent
50474-803NeuprorotigotineUCB, Inc.NDACurrent
50474-804NeuprorotigotineUCB, Inc.NDACurrent
50474-804NeuprorotigotineUCB, Inc.NDACurrent
50474-804NeuprorotigotineUCB, Inc.NDACurrent
50474-804NeuprorotigotineUCB, Inc.NDACurrent
50474-804NeuprorotigotineUCB, Inc.NDACurrent
50474-805NeuprorotigotineUCB, Inc.NDACurrent
50474-805NeuprorotigotineUCB, Inc.NDACurrent
50474-805NeuprorotigotineUCB, Inc.NDACurrent
50474-805NeuprorotigotineUCB, Inc.NDACurrent
50474-805NeuprorotigotineUCB, Inc.NDACurrent
50474-806NeuprorotigotineUCB, Inc.NDACurrent
50474-806NeuprorotigotineUCB, Inc.NDACurrent
50474-806NeuprorotigotineUCB, Inc.NDACurrent
50474-806NeuprorotigotineUCB, Inc.NDACurrent
50474-806NeuprorotigotineUCB, Inc.NDACurrent
50474-808NeuprorotigotineUCB, Inc.NDACurrent
50474-808NeuprorotigotineUCB, Inc.NDACurrent
50474-808NeuprorotigotineUCB, Inc.NDACurrent
50474-808NeuprorotigotineUCB, Inc.NDACurrent
50474-808NeuprorotigotineUCB, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
68089SUPPL2021-07-14
68088SUPPL2021-07-14
68075SUPPL2021-07-14
68074SUPPL2021-07-14
62825SUPPL2020-05-05
62694SUPPL2020-04-28
62688SUPPL2020-04-27
62447SUPPL2020-04-06
57300SUPPL2019-01-22
57289SUPPL2019-01-22
56818SUPPL2018-12-20
56601SUPPL2018-11-30
16430SUPPL2015-03-02
28670SUPPL2015-02-27
28669SUPPL2012-04-04
6274SUPPL2012-04-04
44992SUPPL2012-04-02
44991SUPPL2012-04-02
37730SUPPL2012-04-02
37729SUPPL2012-04-02
21836ORIG2007-07-02
28668ORIG2007-05-16
23076ORIG2007-05-10
16429ORIG2007-05-10